RNS Number : 0529V
Fintel PLC
09 December 2021
 

Fintel plc

(the "Company" or "Fintel")

Issue of Shares

 

Fintel plc (AIM: FNTL) announces that it has issued 16,091 ordinary shares of £0.01 each to satisfy certain share entitlements of certain employees who have elected to exercise their options pursuant to the Company's Save As You Earn ("SAYE") employee share scheme.

Application has been made for the 16,091 newly issued shares to be admitted to trading on AIM, and admission is expected to take place on 14 December 2021 ("Admission"). Following Admission, the Company's issued share capital will consist of 102,878,830 ordinary shares. There are no ordinary shares held in treasury. Therefore, following Admission, this figure of 102,878,830 should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

Fintel plc                                                                                                               via Instinctif Partners

Matt Timmins (Joint Chief Executive Officer)

Neil Stevens (Joint Chief Executive Officer)

 

Zeus Capital (Nominated Adviser and Joint Broker)                                     +44 (0) 20 3829 5000

Martin Green

Dan Bate

 

Investec Bank (Joint Broker)                                                                             +44 (0) 20 7597 5095

Bruce Garrow

David Anderson

Harry Hargreaves

 

Instinctif Partners (Financial PR)                                                                       +44 (0) 20 7457 2020

Mark Walter                                                                                                         fintel@instinctif.com

Andy Lane 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOELVLLBFLLXFBB